FDA Worried Your Donated Organs Might Come With Tuberculosis
Published Date: 1/7/2025
Notice
Summary
The FDA just dropped new rules to help companies that handle human cells and tissues keep tuberculosis (TB) from spreading. These rules tell them how to check donors for TB risks and what extra steps to take until better TB tests are ready. This change starts right away and helps protect everyone who gets these medical products without adding big costs.
Analyzed Economic Effects
3 provisions identified: 3 benefits, 0 costs, 0 mixed.
New Donor TB Screening Recommendations
On January 7, 2025, the FDA issued a final guidance that establishments that make donor eligibility determinations for human cells, tissues, and cellular and tissue‑based products (HCT/Ps) should screen donors for evidence of, and risk factors for, Mycobacterium tuberculosis (Mtb) infection. The guidance is immediately available for implementation and is intended to reduce the risk that transplanted HCT/Ps transmit tuberculosis.
Interim Steps Until TB Tests Available
The guidance recommends that HCT/P establishments take additional steps to reduce Mtb transmission risk until appropriate FDA‑licensed, approved, or cleared donor screening tests for Mtb infection are available. These interim recommendations are part of the final guidance that the FDA made available on January 7, 2025.
Mtb Now Identified As RCDAD
The guidance identifies Mycobacterium tuberculosis (Mtb) as a relevant communicable disease agent or disease (RCDAD) under 21 CFR 1271.3(r)(2) and states that it supplements other donor eligibility guidance for HCT/P donors. FDA cites multistate outbreaks in 2021 and 2023 as context for this designation.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Related Federal Register Documents
2026-11331 — Hand Trucks and Certain Parts Thereof From the People's Republic of China: Final Results of the Expedited Fourth Sunset Review of the Antidumping Duty Order
The U.S. Department of Commerce decided to keep the antidumping duties on hand trucks and parts from China because dropping them could lead to unfair low prices again. This means importers from China will still pay extra fees to keep things fair for U.S. businesses. These rules stay in effect starting June 5, 2026, protecting American companies from cheap imports that could hurt them.
2026-11280 — Self-Regulatory Organizations; NYSE American LLC; Order Instituting Proceedings To Determine Whether To Approve or Disapprove a Proposed Rule Change To Amend Sections 1003 and 1009 of the NYSE American Company Guide
The NYSE American Exchange wants to change its rules to require companies to keep a certain market value to stay listed. This affects companies listed on the exchange and could lead to some being removed if they don’t meet the new standards. The SEC is reviewing this change and will decide by June 18, 2026, so companies and investors should watch for updates that might impact stock listings and market activity.
2026-11296 — Notice of Determinations and Request for Comments Concerning Actions in Section 301 Investigations of Acts, Policies, and Practices of Various Economies Related to the Failure To Impose and Effectively Enforce a Prohibition on the Importation of Goods Produced With Forced Labor
The U.S. Trade Representative found that many countries aren’t stopping goods made with forced labor from entering the U.S. To fix this, they’re planning to add extra taxes (tariffs) on products from these countries, with rates between 10% and 12.5%. They’re also offering a special deal for some clothing imports and want your thoughts before finalizing these changes by early July 2026.
2026-11327 — Proposed Revisions to the National Handbook of Conservation Practices
The USDA’s Natural Resources Conservation Service is updating some rules in the National Handbook of Conservation Practices to help farmers and landowners protect the environment better. These changes could affect how conservation projects are planned and done, and the public can share their thoughts until July 6, 2026. No big costs are expected, but the updates aim to make conservation easier and more effective.
2026-11276 — Long Island Rail Road's Request To Amend Its Positive Train Control System
The Long Island Rail Road wants to make some changes to its safety system that helps prevent train crashes, called Positive Train Control (PTC). They asked the government for approval on May 21, 2026, and now the public can share their thoughts until June 25, 2026. These updates aim to keep trains safer without causing delays or extra costs for riders.
2026-11282 — Self-Regulatory Organizations; Cboe Exchange, Inc.; Notice of Designation of a Longer Period for Commission Action on a Proposed Rule Change To Amend It Rules Related to Binary Options
The Cboe Exchange wants to update its rules to let traders buy and sell binary options on more indexes, with flexible settlement times and new position limits. The SEC is taking extra time, until July 19, 2026, to review these changes carefully. This affects traders and could impact how they manage risk and trade binary options on the Exchange.
Previous / Next Documents
Previous: 2024-31543 — Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations; Draft Guidance for Industry and Food and Drug Administration Staff; Availability
The FDA just dropped a draft guide to help companies make and sell medical devices with AI software. It explains what info to include so the FDA can check these devices are safe and work well, plus tips on managing them from start to finish. If you’re in the AI medical device game, get ready to share your thoughts by April 7, 2025, before the rules get final—and yes, this could affect your product plans and budgets.
Next: 2024-31545 — Interim Policy on Compounding Using Bulk Drug Substances Under Section 503B of the Federal Food, Drug, and Cosmetic Act; Guidance for Industry; Availability
The FDA just released a new interim policy for pharmacies that mix medicines using bulk drug ingredients. This update affects outsourcing facilities by setting clearer rules while the FDA finishes a list of approved bulk drugs. Starting January 7, 2025, these changes help keep medicines safe without slowing down production or adding extra costs right now.